Immunai, an AI biotech company specializing in mapping the human immune system, has announced a strategic collaboration with ...
The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results